Login

JV Partners Seeked by Avrupa Minerals CEO for European Assets | Paul Kuhn, President & CEO, Avrupa Minerals Ltd. (IE) 00:10:00

Share On Facebook Share On Twitter

President & CEO

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Fostering Societal Contribution Beyond Profit: A Call for Wildlife Conservation |Harald Link, CEO, B Grimm Power PCL.
00:10:00
Graeme Bevans, Managing Director and CEO of Atlas Arteria (ASX:ALX), presents during the August 2020 Reporting Season.|Graeme Bevans is an Executive Director of ATLAX
00:10:00
CSE Global T.V. | Lim Boon Kheng, CEO, CSE Global Ltd 544:SES
00:10:00
Welcome to Precedent Asset Management with Kenneth Kola Bundy
00:10:00
City of Chandler Economic Development Director, Micah Miranda, engages in discussions with Dan Berenbaum, Chief Financial Officer of Everspin.
00:10:00
Evolution Energy Minerals Advances Chalalo Graphite Project in Tanzania Amidst Positive Regulatory Outlook
00:10:00
Ionic Rare Earths: Advancing a Major Rare Earth Project in Uganda and Expanding Downstream Capabilities
00:00:00
OptiBiotix secures exclusive manufacturing agreement for CE marked SlimBiome - Stephen Patrick O'Hara CEO / Founder, OptiBiotix Health
00:00:00
Alimera Sciences - RICK EISWIRTH President and Chief Executive Officer, Alimera Sciences Inc
00:10:00
Navigating Darkness: Writing Memoirs of Mental Illness|Meg Kissinger,Professor,Columbia University
00:10:00
Award-Winning Performance: Insights from Nicolas Walewski of Alken | Nicolas Walewski - CEO, Founder & Portfolio Manager, Alken
00:10:00
"Strategic Mastery in Investment: Howard Marks' Insights at Norges Bank Investment Management's Annual Investment Conference 2024"

© 2026 Nehu